[Novel model of replicative Legionella pneumophila lung infection in DBA/2 mice]

Yoshinori Kashimoto1, Yuichi Kurosaka, Yukie Karibe

  • 1Daiichi Sankyo Co. Ltd., Biological Research Laboratories IV.

Insights

This study establishes a new mouse model for Legionella pneumophila lung infection. The model aids in understanding bacterial pathogenesis and evaluating new therapies for Legionella pneumonia.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Context:

  • Legionella pneumophila causes Legionnaires' disease, a severe form of pneumonia.
  • DBA/2 mice are utilized to establish a persistent, non-lethal lung infection model.
  • Cyclophosphamide treatment exacerbates infection, leading to lethal outcomes.

Purpose:

  • To develop and characterize a novel mouse model for studying Legionella pneumophila lung infection.
  • To investigate the histopathological and cellular responses during infection.
  • To provide a platform for evaluating antibacterial therapies.

Summary:

  • Intranasal inoculation of L. pneumophila in DBA/2 mice established a persistent lung infection.
  • Histopathology revealed neutrophil and macrophage infiltration, followed by lymphocyte migration.
  • Transmission electron microscopy confirmed intracellular bacterial location within neutrophils.

Impact:

  • This replicative L. pneumophila lung infection model offers a valuable tool for pathogenesis research.
  • It serves as a method for assessing the efficacy of antibacterial treatments against Legionella.
  • The model facilitates a deeper understanding of host-pathogen interactions in pneumonia.

Related Concept Videos